Shenzhen Glory Medical Co.,Ltd. - Laporan Laba Rugi (TTM)

Shenzhen Glory Medical Co.,Ltd.
CN ˙ SZSE
CN¥ 4.17 ↑0.03 (0.72%)
2025-09-05
BAHAGING PRESYO
Laporan Laba Rugi (TTM)

Laporan Laba Rugi Shenzhen Glory Medical Co.,Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2022
01-01
2022
03-31
2022
06-30
2022
09-30
2023
01-01
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 1,918 2,267 2,458 2,173 1,874 1,790 1,725 1,546 1,578 1,276 1,101 1,248 1,254 1,193 1,160 1,224 1,277 1,448 1,452 1,345
Change (%) 18.22 8.40 -11.58 -13.78 -4.45 -3.66 -10.39 2.13 -19.18 -13.69 13.35 0.51 -4.91 -2.79 5.58 4.28 13.43 0.25 -7.37
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 1,373 1,573 1,667 1,519 1,316 1,470 1,525 1,399 1,436 1,060 894 1,022 1,043 1,038 1,015 1,089 1,136 1,195 1,205 1,103
Change (%) 14.55 5.95 -8.84 -13.36 11.71 3.68 -8.26 2.65 -26.16 -15.63 14.23 2.10 -0.51 -2.17 7.23 4.39 5.15 0.84 -8.50
% of Revenue 71.60 69.38 67.81 69.92 70.25 82.13 88.39 90.49 90.96 83.10 81.24 81.87 83.16 87.01 87.56 88.92 89.01 82.52 83.00 81.99
Gross Operating Profit 545 694 791 654 557 320 200 147 143 216 207 226 211 155 144 136 140 253 247 242
Change (%) 27.47 13.95 -17.37 -14.73 -42.61 -37.42 -26.62 -2.88 51.08 -4.17 9.56 -6.64 -26.63 -6.90 -5.99 3.39 80.51 -2.54 -1.85
% of Revenue 28.40 30.62 32.19 30.08 29.75 17.87 11.61 9.51 9.04 16.90 18.76 18.13 16.84 12.99 12.44 11.08 10.99 17.48 17.00 18.01
SG&A 230 214 278 223 236 177 130 178 165 285 292 249 241 206 193 194 202 174 150 158
Change (%) -6.94 30.11 -20.07 5.99 -24.95 -26.63 37.22 -7.41 72.83 2.27 -14.74 -3.09 -14.40 -6.41 0.72 4.04 -14.07 -13.77 5.24
% of Revenue 11.99 9.44 11.33 10.24 12.59 9.89 7.53 11.53 10.46 22.36 26.49 19.93 19.21 17.30 16.65 15.88 15.85 12.01 10.33 11.73
R&D 53 61 63 59 55 52 49 49 49 48 43 46 45 40 40 39 39 41 49 44
Change (%) 16.03 2.76 -6.28 -6.60 -4.83 -5.85 0.29 -0.87 -1.71 -10.83 7.25 -3.03 -10.32 0.28 -4.01 0.80 4.89 19.07 -10.17
% of Revenue 2.75 2.70 2.56 2.71 2.94 2.93 2.86 3.20 3.11 3.78 3.90 3.69 3.56 3.36 3.47 3.15 3.05 2.82 3.35 3.24
OpEx 1,674 1,867 2,030 1,822 1,629 1,722 1,726 1,645 1,669 1,412 1,249 1,338 1,352 1,304 1,268 1,346 1,401 1,432 1,427 1,331
Change (%) 11.53 8.74 -10.24 -10.57 5.70 0.21 -4.71 1.47 -15.40 -11.50 7.09 1.03 -3.51 -2.74 6.12 4.10 2.19 -0.33 -6.72
% of Revenue 87.27 82.33 82.59 83.84 86.96 96.20 100.07 106.41 105.72 110.67 113.47 107.20 107.75 109.33 109.38 109.94 109.76 98.88 98.30 98.99
Operating Income 244 401 428 351 244 68 -1 -99 -90 -136 -148 -90 -97 -111 -109 -122 -125 16 25 14
Change (%) 64.10 6.80 -17.95 -30.39 -72.13 -101.70 8,436.48 -8.75 50.63 8.99 -39.40 8.11 14.56 -2.27 11.83 2.35 -113.06 51.54 -44.85
% of Revenue 12.73 17.67 17.41 16.16 13.04 3.80 -0.07 -6.41 -5.72 -10.67 -13.47 -7.20 -7.75 -9.33 -9.38 -9.94 -9.75 1.12 1.70 1.01
Interest Expense -16 -17 -18 -16 -9 -7 -4 -5 -3 -4 -4 -4 -5 -2 -2 -2 -2 -6 -7 -18
Change (%) 6.26 3.70 -9.08 -43.75 -19.80 -38.93 4.70 -38.76 57.11 0.03 -15.83 22.71 -56.39 -10.89 11.63 -2.03 198.70 15.86 170.90
% of Revenue -0.83 -0.75 -0.72 -0.74 -0.48 -0.40 -0.26 -0.30 -0.18 -0.35 -0.40 -0.30 -0.37 -0.17 -0.15 -0.16 -0.15 -0.40 -0.47 -1.36
Net Income 130 162 173 143 110 45 3 -75 -76 -308 -311 -252 -250 -149 -142 -146 -148 22 22 0
Change (%) 24.50 6.90 -17.35 -23.40 -59.43 -93.15 -2,546.52 1.78 305.42 1.11 -18.99 -1.05 -40.36 -4.60 3.08 0.86 -115.09 0.36 -97.78
% of Revenue 6.79 7.15 7.05 6.59 5.86 2.49 0.18 -4.83 -4.81 -24.15 -28.29 -20.22 -19.90 -12.48 -12.25 -11.96 -11.57 1.54 1.54 0.04

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista